Trial Profile
Efficacy of Eculizumab in Patients with Paroxysmal Nocturnal Haemoglobinuria
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2014
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Paroxysmal nocturnal haemoglobinuria
- Focus Therapeutic Use
- 02 Jul 2014 New trial record